Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2000, p. 1609-1614, Vol. 38, No. 4
Istituto di Microbiologia, Università
Cattolica del Sacro Cuore, Rome,1 and
Istituto di Microbiologia, Università degli Studi di
Milano, Milan,2 Italy
Received 1 October 1999/Returned for modification 3 November
1999/Accepted 16 December 1999
A PCR-based assay was developed to detect and identify medically
important yeasts in clinical samples. Using a previously described set
of primers (G. Morace et al., J. Clin. Microbiol. 35:667-672,
1997), we amplified a fragment of the ERG11 gene for cytochrome P-450 lanosterol 14
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Reverse Cross Blot Hybridization Assay for Rapid Detection of
PCR-Amplified DNA from Candida Species, Cryptococcus
neoformans, and Saccharomyces cerevisiae in
Clinical Samples
-demethylase, a crucial enzyme in the
biosynthesis of ergosterol. The PCR product was analyzed in a reverse
cross blot hybridization assay with species-specific probes directed to
a target region of the ERG11 gene of Candida albicans (pCal), C. guilliermondii (pGui),
C. (Torulopsis) glabrata (pGla),
C. kefyr (pKef), C. krusei (pKru), C. parapsilosis (pPar), C. tropicalis (pTro), the newly
described species C. dubliniensis (pDub),
Saccharomyces cerevisiae (pSce), and Cryptococcus
neoformans (pCry). The PCR-reverse cross blot hybridization assay
correctly identified multiple isolates of each species tested. No
cross-hybridization was detected with any other fungal, bacteria, or
human DNAs tested. The method was tested against conventional
identification on 140 different clinical samples, including blood and
cerebrospinal fluid, from patients with suspected fungal infections.
The results agreed with those of culture and phenotyping for all but
six specimens (two of which grew yeasts not included in the PCR panel
of probes and four in which PCR positivity-culture negativity was
justified by clinical findings). Species identification time was
reduced from a mean of 4 days with conventional identification to
7 h with the molecular method. The PCR-reverse cross blot
hybridization assay is a rapid method for the direct detection and
identification of yeasts in clinical samples.
*
Corresponding author. Mailing address: Istituto di
Microbiologia, Università degli Studi di Milano, Via Pascal, 36, 20133 Milan, Italy. Phone: 39-02-26601215. Fax: 39-02-26601218. E-mail: giulia.morace{at}unimi.it.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»